Evidence map›Paper›PMID 24481567›Full record

ArticlePsychopharmacology2014

Assessment of the kappa opioid agonist, salvinorin A, as a punisher of drug self-administration in monkeys.

Kevin B Freeman, Jennifer E Naylor, Thomas E Prisinzano, William L Woolverton

Open access · greenAbstract read
In one paragraph

Article in Psychopharmacology, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 30 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
30citing papers in PubMed, 2 pooled it
3.6field-weighted citation impact, top 7% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

30 citing papers in PubMed, 2 syntheses or guidelines pooled it, 65 citations in OpenAlex.

  1. Pooled it
  2. A review of the kappa opioid receptor system in opioid use.Neuroscience and biobehavioral reviews · 2024
    Pooled it
  3. Article
  4. Review
  5. Article
  6. Article
  7. Article
  8. Article
  9. Review
  10. Article
  11. Article
  12. Article
  13. Pharmacokinetics and Pharmacodynamics of Salvinorin A andPharmaceuticals (Basel, Switzerland) · 2021
    Review
  14. Article
  15. Article
  16. Review
  17. Article
  18. Article
  19. The Rise and Fall of Kappa-Opioid Receptors in Drug Abuse Research.Handbook of experimental pharmacology · 2020
    Review
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 2 institutions in 1 country.

Kevin B FreemanDivision of Neurobiology and Behavior Research, Department of Psychiatry and Human Behavior, The University of Mississippi Medical Center, Jackson, MS, 39216, USA, kfreeman@umc.edu.
Jennifer E Naylor
Thomas E Prisinzano
William L Woolverton
University of Mississippi Medical Center · USUniversity of Kansas · US

Funding

Investigation of Neoclerodanes as Novel Opioid LigandsR01DA018151 · NIDA · UNIVERSITY OF KENTUCKY · PI PRISINZANO, THOMAS EDWARD · 2005 to 2020
$5.7M
Self-administration of drug combinations: Polydrug abuseR01DA019471 · NIDA · UNIVERSITY OF MISSISSIPPI MED CTR · PI WOOLVERTON, WILLIAM L. · 2006 to 2010
$1.6M
Temporal Discounting of Punishment of Drug ChoiceR21DA026832 · NIDA · UNIVERSITY OF MISSISSIPPI MED CTR · PI WOOLVERTON, WILLIAM L. · 2009 to 2010
$296k
NIDA NIH HHS DA018151NIDA NIH HHS DA019471NIDA NIH HHS DA026832NIDA NIH HHS R01 DA018151NIDA NIH HHS R01 DA019471NIDA NIH HHS R21 DA026832
6 · The paper itself

Abstract

rationaleDrugs can function as punishers. However, work on the study of drugs as punishers is limited, as is the range of compounds known to function as punishers. Kappa opioid agonists, which have received much experimental attention as potential therapeutics for drug abuse, reportedly produce aversive effects. However, kappa agonists have yet to be tested as punishers of behavior.

objectiveThe goal of the current study was to determine if a kappa agonist could function as a punisher of drug self-administration.

methodIn separate experiments, monkeys were allowed to choose in a two-lever choice design between intravenous injections of equal doses of either cocaine (0.1 mg/kg/injection on each lever) or remifentanil (0.1 μg/kg/injection on each lever) when one of the two options was mixed with various doses of the kappa agonist, salvinorin A.

resultsChoice for the cocaine and remifentanil options that were combined with salvinorin A decreased as a function of salvinorin A dose in all monkeys. However, operant response rates were not systematically affected by salvinorin A administration.

conclusionThe present findings demonstrate that the kappa agonist, salvinorin A, can punish self-administration of a psychotimulant, cocaine, and a mu opioid, remifentanil. In consideration of these findings, it may be possible to curtail the abuse of some drugs by contingently delivering kappa agonists (e.g., as combination formularies for prescription medications).

Indexed as

PunishmentAnalgesics, OpioidAnimalsBehavior, AnimalChoice BehaviorCocaineConditioning, OperantDiterpenes, ClerodaneMacaca mulattaMalePiperidinesReceptors, Opioid, kappaRemifentanilSelf AdministrationAnalgesics, OpioidCocaineDiterpenes, ClerodanePiperidinesReceptors, Opioid, kappaRemifentanilsalvinorin A

Identifiers

PMID24481567
PMCPMC4074245
OpenAlexW2013501854

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.